Type
Contribution à un site web
Titre
Indian Pharma: A Global Leader Under Pressure
Dans
Institut Montaigne
Auteur(s)
JAFFRELOT Christophe - Centre de recherches internationales (Auteur)
JUMLE Vihang - WWF India (Auteur)
KISHOR Maitreyee - Ashoka University (Auteur)
Mots clés
India, Covid-19, pharmaceutical industry
Résumé
EN
India is a global supplier of generic drugs. Its export-oriented pharmaceutical industry is extremely profitable but encounters a number of challenges, from domestic demand to human resources. The Covid-19 pandemic has brought to light its dependence on imports from China of active pharmaceutical ingredients and chemical intermediates. As the whole world discusses how to increase the resilience of supply chains, could this be an opportunity for a Europe-India cooperation? This is the theme of the last article of our new series on India’s health sector, by Christophe Jaffrelot, Senior Research Fellow at CERI-SciencesPo/CNRS, Vihang Jumle, Project Officer at TRAFFIC WWF India and Maitreyee Kishor, a Sciences Po graduate who works at Ashoka University's Centre for Writing and Communication.

CITATION BIBLIOGRAPHIQUE
EXPORT